26 Mar 2026Open access
Implementing less invasive surfactant administration in Nigeria: a prospective cohort study with a retrospective matched controlPublisher siteThe Lancet Regional Health - Africa, Neonatal Respiratory Health Research
UniversitiesChineye Umukoro
Active, last published 2026
In neonatal respiratory health research
Chineye
Umukoro
Scholar“Research focused on Neonatal Respiratory Health Research and adjacent fields.”
Federal Medical Centre
Claim Your Profile1
H-index
4
Citations
Chineye has not officially claimed their profile. If you are Chineye, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
hineye Umukoro is a researcher working on Neonatal Respiratory Health Research. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Chineye's work has been cited 4 times across 2 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Neonatal Respiratory Health Research×2Emergency and Acute Care Studies×1
04 · Where I am
Affiliations
Affiliation on published researchFederal Medical CentreDrawn from the institution listed on this researcher’s published work.
05 · Selected work
Recent publications
2 works1 Jan 2025Open access
Implementing Less Invasive Surfactant Administration in Nigeria: A prospective cohort study with a retrospective matched controlPublisher siteSSRN Electronic Journal, Environmental and Sediment Control
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Chineye?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you